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Abstract
Background The laparoscopic Roux-en-Y gastric bypass
(LRYGB) has been the gold standard for bariatric surgery,
but recently, the laparoscopic sleeve gastrectomy (LSG) has
gained popularity. At present, limited data is available on the
long-term complications of these two types of surgery. The
aim of this retrospective study was to compare the 2-year data
about late (more than 30 days after surgery) complications that
were treated surgically or endoscopically after LRYGB and
LSG operations in a large hospital area with a single patient
database.
Materials This was a retrospective, non-randomized, single-
center study of 760 (545 LRYGB and 215 LSG) bariatric
patients surgically treated between 2008 and 2013 in the
Bariatric Surgery Unit of Helsinki University Central
Hospital.
Methods The patients were followed for 2 years, and late
complications (more than 30 days after surgery) that were
surgically and/or endoscopically treated were registered.
Weight loss and the risk factors for complications were also
monitored.
Results The study found a difference between the LRYGB
and LSG patients in a number of late complications treated
by both intervention types: surgical intervention were required
in 9.4% of LRYGB patients vs. 0.9 of LSG patients, and
endoscopic intervention were required by 4.6% of LRYGB
patients vs. 1.4% of LSG patients (both p < 0.05). The risk
of surgical complications was increased by better weight loss
results in 12 months.
Conclusions LRYGBwas found to be associated with a great-
er risk of late complications. If larger databases confirm these
results, the trend toward LSG is justified.
Keywords Bariatric surgery . Late complications . LSG .
LRYGB
Introduction
Obesity is a chronic disease said to result from a combination
of environmental and genetic factors [1]. In the USA, it is the
second most common cause of preventable deaths [2]. In
2013, the number of bariatric procedures worldwide was esti-
ma ted a t 468 ,609 and 95 .7% were ca r r i ed ou t
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Roux-en-Y gastric bypass (RYGB) (45%), sleeve gastrectomy
(SG) (37%), and adjustable gastric banding (10%). Between
2003 and 2013, there was a significant increase in the popu-
larity of SG, from 0 to 37% [3].
The laparoscopic RYGB (LRYGB) has been the gold stan-
dard for bariatric surgery, but lately, the laparoscopic SG
(LSG) has been gaining popularity [4]. The Cochrane
Update review of bariatric surgery stated that LRYGB and
LSG are comparable in terms of improvement of comorbidi-
ties and weight loss [5]. However, recent data suggest that
LRYGB might have more early and late complications than
LSG [6, 7], which could further change the relative popularity
of these surgery types in the future.
Limited data are available on the number of late complica-
tions after LRYGB and LSG. Usually, patients with early post-
operative complications are treated in specialized bariatric sur-
gery centers, but patients who develop later complications may
seek treatment at local surgical units, leading to gaps in the data.
The aim of this retrospective study was to compare the 2-
year data on late (more than 30 days after surgery) complica-
tions of LRYGB and LSG operations that were surgically or
endoscopically treated in a large hospital area with a single
patient database.
Methods
This was a retrospective, non-randomized study of 760 bariat-
ric patients surgically treated between 2008 and 2013 at Peijas
Hospital, in the Bariatric Surgery Unit of Helsinki University
Central Hospital. The retrospective data included both prima-
ry and revisional bariatric surgery patients. There were origi-
nally 772 patients, of which 12were excluded. These included
2 gastric bandings, 9 band removals, and 1 duodenal switch.
Therefore, the study included only LRYGB and LSG patients.
Preoperatively, the patients had undergone medical, nutri-
tional, and psychological screening. The patients had been
selected using criteria similar to those recommended in the
European Guidelines on Metabolic and Bariatric Surgery
[8]. Preoperative upper stomach ultrasound and gastroscopy
had been performed. If a Helicobacter pylori infection had
been diagnosed, it was treated prior to the operation.
Diagnosed gallstones had not been removed prior to the bar-
iatric operation but rather, if symptomatic, were removed elec-
tively from 2 to 6 months after the bariatric surgery.
The selection of operation type was generally based on the
surgeons’ and patients’ preferences. LSG was recommended
for patients who were extremely obese or had extra risk fac-
tors, including severe intra-abdominal adhesions after previ-
ous abdominal operations, liver cirrhosis, chronic obstructive
pulmonary disease, chronic renal failure, coagulopathy, and
risk factors for malignancy in the stomach. However, in
2009–2010, Peijas Hospital took part in a multicenter study
in which the type of operation was randomized between
LRYGB and LSG [9].
The present study followed bariatric patients in the hospital
district for 2 years and registered their late surgical complica-
tions. We also monitored weight loss. The first follow-up was
at 1 month postoperatively and was conducted by the surgeon;
thereafter, follow-ups were conducted by an endocrinologist
at 3, 6, 12, and 24 months. In addition, the patients were
requested to contact the hospital if they had problems that they
thought were related to their bariatric surgery.
During the 2-year follow-up period, 10 patients died of
causes unrelated to the bariatric surgery, 78 were followed in
other hospital districts, and 3 refused the follow-ups.
However, these patients were included in the study, because
their problems related to obesity surgery were treated in the
study hospital.
As a primary endpoint, the present study monitored the
numbers of late surgical complications of LRYGB and LSG,
including those treated with either surgical or endoscopic in-
terventions. Potential risk factors, including weight loss, age,
gender, and comorbidities, were analyzed. In addition, the
time between the primary operation and the first intervention
for complication was analyzed. Data were collected prospec-
tively by the authors. The study was approved by the Finnish
Ethical Committee.
Operation Techniques
Gastric Bypass Two 12-mm and three 5-mm dilating ports
were used, three on the left side of the abdomen, one on the
right side, and one under the xiphoideum to hold the liver
retractor. A 20-ml gastric pouch was formed with three to five
linear stapler firings (Endo-GIA; Medtronic; Minneapolis,
MN, USA). The first 100 gastro-jejunal anastomoses were
formed using a circular stapler technique (Circular stapler;
Orvil; Medtronic; Minneapolis, MN, USA) and, thereafter,
using a linear stapler technique, with hand-sewing employed
to close the stapler-device hole. The length of the
biliopancreatic channel was between 60 and 80 cm and that
of the alimentary channel 150 cm. The loop was ante-colic.
The jejuno-jejunal anastomosis was made with a linear stapler
and hand-sewing to close the stapler-device hole. The biliary
and alimentary channels were divided after the entero-
anastomosis was formed. Meso-openings were closed using
various methods and absorbable or non-absorbable suturing or
metallic clips. The gastro-jejunal anastomosis was tested
using 50 ml of methylene blue dye.
Sleeve Gastrectomy Two 12-mm and one 5-mm dilating
ports were employed on the left upper abdomen, one 15-mm
port on the right abdomen, and one 5-mm port under the
xiphoideum to hold the liver retractor. The sleeve was formed
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with the help of a 35-Fr boogie. The procedure was initiated
by dividing the vessels along the greater curvature, from 6-cm
proximal from the pylorus up to the angle of Hiss, and the
adhesions behind the stomach were cut. The resection was
started from the antrum, with 45- and 60-mm green staplers
(Endo-GIA; Medtronic; Minneapolis, MN, USA) and then
with green/golden 60-mm staplers along the boogie and up
to the angle of Hiss, where a 1-cm corner of stomach was left.
Reinforcements (Peri-Strip dry; Synovis; USA) were used on
the stapler line, and the line was tested with 200 ml of meth-
ylene blue dye.
Statistical analysis was performed using SPSS version 21
(IBMCorp.; New York, NY, USA) and SAS version 9.4 (SAS
Systems; SAS Institute Inc.; Cary, NC, USA). Categorical
variables are presented as numbers (n) and percentages (%)
and continuous variables as means and standard deviations
(SD) or medians and interquartile ranges (IQR). Continuous
data were tested for normality using the Shapiro-Wilk test.
Differences in continuous variables between groups were an-
alyzed using the Kruskal-Wallis test or the Mann-Whitney U
test, and differences in binominal or categorical variables were
analyzed using the Fisher’s exact test or the Fisher-Freeman-
Halton test. Univariate and multivariate logistic regression
were used to identify significant risk factors for complications.
The Firth’s penalized logistic regression was used in multivar-
iate regression regarding complications without cholecystec-
tomies. The excess weight loss percentage (EWL %) was
calculated as the ideal body weight to yield a bodymass index
(BMI) of 25 kg/m2.
Results
The study included 760 patients, 545 LRYGB (71.7%) and
215 LSG (28.3%), of whom 68.9%were female. The LRYGB
and LSG patient groups were similar regarding gender, co-
morbidities, and previous operations but not regarding age
and pre-operative weight (Table 1).
There were 60 surgical interventions among the LRYGB
patients. However, 6 patients had more than 1 surgical inter-
vention or had 2 different diagnoses for a single operation;
thus, the final number of LRYGB patients with operative com-
plications was 51, and the number of LSG patients was 2. Four
LSG patients were treated endoscopically, but one had two
interventions, so the total number of patients with endoscopic
complications was three. There was a significant difference in
the number of patients in the LRYGB and LSG groups who
were treated with both intervention types: 9.4% of LRYGB
patients were treated surgically vs. 0.9% of LSG patients, and
4.6% of LRYGB patients were treated endoscopically vs.
1.4% of LSG patients (both p < 0.05) (Table 2).
Table 3 presents the complications that were treated surgi-
cally without cholecystectomies. In this table, the total number
of patients treated was 31 in the LRYGB group and 0 in the
LSG group. There was a significant difference (p < 0.001)
between the groups.
The mean percentages of excess weight loss (EWL%) at 1
and 2 years after the procedure differed between the two pro-
cedures, with those having undergone LRYGB losing more
(Table 4).
The mean time until the first surgical intervention was
390 days for LRYGB and 388 days for LSG patients
(p = 0.98), and for endoscopic interventions, it was 127 days
for LRYGB and 209 days for LSG patients (p = 0.61)
(Table 4). Figure 1 presents the timeline for the most common
complications.
Multivariate logistic regression analysis (Table 5) found
that for complications treated surgically, 12-month total
weight loss was a risk factor and LSG was a preventative
factor. Table 6 presents a logistic regression model without
cholecystectomies, which shows similar findings. Neither
age, gender, nor comorbidities affected the risk of complica-
tions in the multivariate model.
In the univariate regression analysis, EWL% in 1 and
2 years were a risk factor for complications and LSG was a
preventive factor. Prior cholecystectomy nor gastric banding
did not affect the risk for surgical complications. However, all
other previous abdominal operations, including ventral hernia,
fundoplication, and cancer operations, were risk factors for
complications. For unknown reasons, the univariate regres-
sion found hypertension to be a factor preventing complica-
tions. Reason for this cannot be explained (Table 7).
Discussion
The short-term complications of bariatric surgery have been
widely recognized and analyzed. However, limited data is
Table 1 Patient data and prior operations
LRYGB LSG p
Patients 545 215
Sex, female 381 (69.9%) 143(66.5%) 0.39
Age, median (IQR) 47 (23–65) 49(24–67) 0.023
Pre-operative BMI (IQR) 44.1(32.4–77.7) 46.6(31.7–72.1) < 0.001
Hypertension 387 (71%) 145(67.4%) 0.34
Diabetes 262 (48.1%) 107(49.8%) 0.68
Hypercholesterolemia 183 (33.6%) 84(39.1%) 0.17
Sleep apnea 160 (29.4%) 70 (32.6%) 0.43
Prior cholecystectomy 80 (14.7%) 38(17.7%) 0.32
Prior gastric banding 6(1.1%) 5(2.3%) 0.31
Prior abdominal surgery 49(9%) 10(4.7%) 0.050
LRYGB laparoscopic Roux-en-Y gastric bypass, LSG laparoscopic sleeve
gastrectomy, IQR interquartile range, BMI body mass index
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available on the long-term complications of LRYGB and LSG
operations.
Internal hernia (IH) is one of the most common complica-
tions of LRYGB and can be fatal [10]. In a study of 594
LRYGB patients, the incidence of IH was 6.2%, and 67.6%
of IHs occurred at the Petersen’s space and 24.3% at the
jejuno-jejunostomy site [10]. In a recent meta-analysis of
31,320 bariatric patients, the incidence of IH varied from 0
to 16% [11], with the lowest incidence (1%) found in groups
in which an ante-colic approach was combined with the clo-
sure of all defects. Among the subjects in the present study, the
incidence of IH was 2.2%, and 50% of the IHs were at the
jejuno-jejunostomy site and 50% were at the Petersen’s space.
As described, the technique at the hospital under study includ-
ed an ante-colic approach and the closure of all meso-open-
ings, using various methods. Because of the few instances of
this complication (12 cases), it was not possible to make a
useful comparison between the closing methods used for in-
stances of IH. In addition, open internal space without IH was
found in a re-operation six times in the Petersen’s space and
four times in the jejuno-jejunostomy site. These defects were
closed during the re-operations. Of the open meso-openings,
whether herniated or not, 22.7% were closed with absorbable
sutures, 13.6% with clips, 22.9% were not closed, and the
dispositions of 54.4% were not mentioned in the patient
records.
Table 2 Endoscopic and surgical
interventions in LRYGB and LSG
patients
Endoscopically treated (%) LRYGB(545) LSG(215) p
Marginal ulcer 13(2.4%) 1(0.5%) 0.13
Stenosis 12(2.2%) 1(0.5%) 0.12
Late fistulae 0 1(0.5%) 0.283
Bezoar 0 1(0.5%) 0.283
Total number of endoscopic complications 25 (4.6%) 4(1.9%)
Total number of patients with endoscopic complications 25(4.6%) 3(1.4%) 0.034
Surgically treated (%)
Internal hernia 12(2.2%) 0 0.024
Incisional hernia 3(0.6%) 0 1
SBO/strangulation 7(1.3%) 0 0.2
Alimentary and biliary limb problems 5(0.9%) 0 0.33
Abdominal pain NAS 4(0.7%) 0 0.58
Perforation 4(0.7%) 0 0.58
Invagination 1(0.2%) 0 1
Fistula, laparoscopically treated 1(0.2%) 0 1
Cholecystectomy
Elective 18(3.3%) 2(0.9%) 0.08
Acute 5(0.9%) 0 0.33
Total number of surgical complications (%) 60(11%) 2(0.9%)
Total number of patients with surgical complications (%) 51(9.4%) 2(0.9%) < 0.001
Three LRYGB patients had two surgical interventions or more than one diagnosis for a single operation and three
patients had three surgical interventions or more than one diagnosis in one operation. One LSG patient had two
endoscopic interventions
LRYGB laparoscopic Roux-en-Y gastric bypass, LSG laparoscopic sleeve gastrectomy, SBO small bowel obstruc-
tion, Abdominal pain NAS abdominal pain without abnormality seen in the operation
Table 3 Surgical interventions in
LRYGB and LSG patients
without cholecystectomies
Surgically treated (%) LRYGB(545) LSG(215) p
Internal hernia 12(2.2%) 0 0.024
Incisional hernia 3(0.6%) 0 0.56
Other surgical problems related to bariatric surgery 22(4%) 0 0.001
Total number of surgical complications (%) 37(6.8%) 0
Total number of patients with surgical complications (%) 31(5.7%) 0 < 0.001
Six LRYGB patients had two surgical interventions or more than one diagnosis for a single operation
LRYGB laparoscopic Roux-en-Y gastric bypass, LSG laparoscopic sleeve gastrectomy
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Another study of 607 LRYGB patients found 25 IHs, of
which 2 occurred in the immediate postoperative period and
23 occurred later, at a mean of 29 months after the operation
[12]. The present study followed patients for only 24 months,
so it is likely that some IHs occurred after that period.
However, in the present study, the mean time for IH diagnosis
was 15 months.
Incisional hernia of the anterior abdominal wall is a com-
mon complication after all abdominal surgeries and untreated,
impairs quality of life [13]. Risk factors for incisional hernia
after bariatric surgery have been shown to include an open
surgical approach, prior abdominal surgery, malnutrition,
and a BMI of more than 60 kg/m2 [14]. Neither procedure
type, complications, nor weight loss is associated with the
occurrence of incisional hernias [15]. In a study of 2161 open
or laparoscopic bariatric patients, 2.4% had an incisional her-
nia [14]. Another study of 1524 laparoscopic bariatric proce-
dures found a 0.5% incidence of trocar port hernias and a
0.9% incidence of abdominal wall hernias [15]. In the present
study, three patients (0.6%) had incisional hernia after their
operations.
Another common complication after LRYGB is small bow-
el obstruction (SBO), which can be caused by adhesion, inter-
nal hernia, incarcerated ventral hernia, or intussusception [6].
The present study found seven (1.3%) SBO/strangulations
and one (0.2%) invagination after LRYGB.
Recurrent abdominal pain can occur after bariatric surgery,
and diagnosis is important to exclude potentially life-
threatening abdominal catastrophes, such as IHs. Diagnoses
are made using computed tomography, endoscopy, and upper
gastrointestinal imaging [16]. However, sometimes the diag-
nosis remains unclear, and diagnostic laparoscopy is required
[16]. The use of diagnostic laparoscopy after bariatric surgery
has not been well documented, although in a small retrospec-
tive study of 13 patients who had undergone diagnostic lapa-
roscopic surgery after bariatric surgery, 2 (15%) had negative
findings [16]. The present study found 4 (0.7%) operations
with negative findings. Nonspecific abdominal pain after bar-
iatric surgery can result from maladaptive eating behavior,
increased food intolerance, constipation, or diarrhea, among
other things [17].
With RYGB, marginal ulceration is seen in from 0.49 to
20% of patients [1]. Risk factors include smoking, diabetes,
long gastric pouch, and Helicobacter pylori [18, 19]. The ul-
ceration is managed by treating the underlying problem, such
as ceasing smoking and adding a proton-pump inhibitor for 3–
6 months [1]. The present study found 13 (2.4%) marginal
ulcerations in LRYGB patients and 1 (0.5%) (p = 0.13) in an
LSG patient. The mean time for ulcers was 21 weeks after the
operation.
Stenosis commonly presents at a rate of 2–12% and at 4–
8 weeks after an LRYGB operation, most commonly occur-
ring at the gastro-enteric anastomoses but sometimes at the
entero-enteric anastomosis [1]. Endoscopic balloon dilation
of stricture/stenosis has proven to be an effective, safe thera-
peutic tool [20]. The number of dilatations needed varies but is
usually from one to four [21]. The present study found 12
(2.2%) cases of stenosis/stricture in LRYGB patients and 1
(0.5%) case in an LSG patient (p = 0.12). The mean time for
stenosis/stricture was 14.1 weeks after the operation.
It has been suggested that incomplete transection of the
gastric pouch and gastric remnant can result in gastro-gastric
fistula after LRYGB. Other common locations of enteric fis-
tula are gastro-cutaneous and gastro-peritoneal [1]. Chronic
Table 4 Excess weight loss
percentage from the operation,
missing patients, and time for the
first intervention
LRYGB(545) LSG(215)
1-year %EWL (SD) 49.7%(21.2) 42.6%(22) < 0.001
1-year missing weight data (%) 101(18.5%) 36(16.7%)
2 years %EWL (SD) 50.5%(22.7) 45.5%(25.2) 0.024
2 years missing weight data (%) 228(41.8%) 72(33.4%)
Time for first surgically treated complication/day(SD) 390(241) 388 (345) 0.98
Time for first endoscopically treated complication/day(SD) 127(160) 209 (262) 0.61
The excess weight loss percentage (%EWL) is calculated of ideal body weight to a BMI of 25 kg/m2
LRYGB laparoscopic Roux-en-Y gastric bypass, LSG laparoscopic sleeve gastrectomy, %EWL excess weight loss
percentage
Fig. 1 Mean time in months for
the most common surgically and
endoscopically treated
complications.
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fistulas are difficult to treat, and laparoscopic and surgical
approaches have been suggested [22]. In LSG, fistula has been
shown to be associated with elevated intraluminal pressure.
Delayed gastric emptying and distal stenosis may play a role
in fistula formation [23]. Over-the-scope clips [24] and endo-
scopic intra-gastric drainage (EID) [25] have been prescribed
for treatment. The present study found one endoscopically
treated late fistula after LSG and one surgically treated late
fistula after LRYGB.
The numbers of endoscopically treated complications dif-
fered significantly between LRYGB and LSG patients, being
4.6 and 1.9%, respectively (p < 0.05).
Known risk factors for biliary complications after bariatric
surgery, including acute and chronic cholecystitis, acute pan-
creatitis, and choledocholithiasis, are rapid weight loss, age
greater than 50, female gender, cholelithiasis at time of bariat-
ric procedure, and RYGB operation [26]. Moon et al. com-
pared the incidences of symptomatic gallstone formation and
cholecystectomy after LRYGB and LSG operations for a
mean of 2 years after the operations, finding no significant
difference between the two operation types [27].
In the present study, 118 patients (15.5%) had had a chole-
cystectomy performed before bariatric surgery. There was no
difference between the LRYGB and LSG groups regarding
the number of prior cholecystectomies (p = 0.32). After the
bariatric operation, 23 (4.2%) LRYGB patients and 2 (0.9%)
LSG patients had a cholecystectomy, which was performed
when 5 (0.9%) of the LRYGB patients and 0 of the LSG
patients (p = 0.32) were in the acute phase. Thus, there was
a significant difference between LRYGB and LSG patients in
the total numbers of acute and elective cholecystectomies, at
4.2 and 0.9%, respectively (p < 0.05). However, some patients
had already been diagnosed with biliary stones before their
operations. Hence, the present study also analyzed the number
of complications without cholecystectomies. The LRYGB
group had 31 surgically treated patients who had complica-
tions without cholecystectomies, and the LSG group had 0.
This difference in the number of patients treated with compli-
cations (p < 0.001) was significant.
A study of 934 LRYGB and 553 LSG patients found a
significant difference in the number of re-operations, including
both early and late complications, and suggested that LRYGB
patients are at a higher risk of re-operation [6]. In addition, a
recent meta-analysis of 340 LRYGB and 345 LSG patients
from randomized studies found no significant difference in late
complications between the operation types but found a non-
statistically significant reduction of 36% in the relative odds
of late complications for the LSG (OR, 0.64; 95% CI, 0.28–
Table 6 Logistic multivariate
regression analyze regarding age,
comorbidities, sex, operation
type, and weight loss regarding
surgical complications without
cholecystectomies
p ODDS Lower (95% CI) Upper (95% CI)
Age > 55 0.162 0.28 0.05 1.52
Age 44–55 0.415 0.81 0.35 1.86
Age < 45 1.00
Sex(female) 0.805 0.90 0.38 2.12
Hypertension 0.081 0.48 0.21 1.09
Diabetes 0.824 0.91 0.40 2.09
LSG 0.027 0.05 0.00 0.71
Initial EWL% 12 months 0.012 1.02 1.01 1.04
The excess weight loss percentage (%EWL) is calculated of ideal body weight to a BMI of 25 kg/m2. Penalized
Firth’s regression
LSG laparoscopic sleeve gastrectomy, %EWL excess weight loss percentage
Table 5 Logistic multivariate
regression analyze regarding age,
comorbidities, sex, operation
type, and weight loss regarding
surgical complications
p ODDS Lower (95% CI) Upper (95% CI)
Age > 55 0.381 0.64 0.23 1.74
Age 44–55 0.405 0.74 0.37 1.50
Age < 45 1.0
Sex (female) 0.868 1.06 0.52 2.15
Hypertension 0.139 0.60 0.30 1.18
Diabetes 0.958 0.98 0.50 1.93
LSG 0.004 0.05 0.01 0.38
Initial EWL% 12 months 0.025 1.02 1.00 1.03
The excess weight loss percentage (%EWL) is calculated of ideal body weight to a BMI of 25 kg/m2
LSG laparoscopic sleeve gastrectomy, %EWL excess weight loss percentage
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1.47; p = 0.3) [28]. The present study found significantly fewer
late complications that were surgically or endoscopically treat-
ed in the LSG group (p < 0.05). The reason for this may be as
follows: LSG is a technically less-demanding operation that
involves less tissue manipulation and avoids creating the ana-
tomical anastomosis and mesenteric traps that can result in IHs
or problems related to changed anatomy. In the present study,
the LSG patients were older and heavier, but, in the adjusted
regression model, age and pre-operative weight did not appear
to be risk factors. Instead, LSG was a protective factor for
surgically treated complications.
It has been stated that rapid weight loss increases the
risk of IHs [29] and biliary complications [26]. In the
present study’s logistic multivariate regression model,
12 months weight loss was a risk factor for surgical com-
plications. In the study, the LSG patients were heavier
before their operations, and their weight reduction was
smaller at both the 1- and 2-year marks than were those
of the LRYGB patients (p < 0.05). However, previous
studies have reported that a higher baseline BMI was a
significant predictor of less weight loss [30]. Because of
the difference in pre-operative weights between the
groups in the present study, weight reduction attributed
to LRYGB and LSG could not reliably be compared.
The present study controlled for weight reduction at 1 and
2 years after the operations, but, 2 years after the operations,
data were missing from 41% of patients’ weight records. This
is because in the later years of the period, studied patients were
being transferred to routine follow-ups in their own healthcare
centers by 1 year after their operations. One-year weight re-
duction was used in the logistic regression model, because it
had a follow-up rate of 75.9%.
The follow-up period after the bariatric operations was
24 months, and, as mentioned, some complications can devel-
op after this time period [12]. Hence, a longer follow-up time
would have provided information on the rates of very late
complications. However, the mean time for first surgical in-
tervention was at 390 days for LRYGB patients and 388 days
for LSG patients (p = 0.98). Therefore, the fact that late com-
plications occurred closer to 1 year after surgery than to 2 years
after suggests that a longer time period for the study was not
needed.
Among the weaknesses of the present study are its retro-
spective nature and that the data were collected from a single
hospital. In addition, it is possible that not all the complica-
tions were registered, because some of the patients were from
different hospital districts, and general surgical problems, in-
cluding cholecystitis and incisional hernia, may have been
treated in different hospitals. However, surgical problems re-
lated directly to bariatric operations, such as IH, were most
likely referred to the hospital involved in the study. In addi-
tion, if some complications were missing from the data, sim-
ilar losses could be expected in both the LRYGB and LSG
groups.
Therefore, despite its limitations, the present study pro-
vides data on late complications after bariatric surgery and
can aid in creating guidelines for choosing a primary bariatric
procedure. If larger databases confirm the clear difference in
late complications between the two operation types, without
significant differences in results, the trend toward LSG noted
here is justified.
Conclusions
Our data strongly support SG as the procedure of choice in
bariatric surgery when it is suitable for the patient.
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Table 7 Logistic univariate regression analyze regarding age, sex,
previous operations, operation type and weight loss regarding surgical
complications
p ODDS Lower (95% CI) Upper (95%CI)
Sex(female) 0.29 1.42 0.74 2.7
Age > 55 0.05 0.42 0.18 1.00
Age 44–55 0.32 0.73 0.40 1.35
Age < 45 1.00
BMI > 55 0.22 0.51 0.17 1.51
BMI 45–55 0.66 1.14 0.64 2.05
BMI > =45 1.00 0.00 0.00
Prior CC 0.106 0.42 0.15 1.20
Prior GB 1.000 0.00 0.00 0.00
Prior other operation 0.044 2.29 1.02 5.11
Hypertension 0.029 0.53 0.30 0.94
Diabetes 0.289 0.74 0.42 1.30
LSG 0.001 0.09 0.02 0.38
EWL%2 years 0.003 1.02 1.01 1.04
EWLkg 2 years 0.004 1.03 1.01 1.05
EWL%1 years 0.001 1.02 1.01 1.04
EWLkg 1 years 0.006 1.03 1.01 1.05
The excess weight loss percentage (%EWL) is calculated of ideal body
weight to a BMI of 25 kg/m2
LSG laparoscopic sleeve gastrectomy%EWL excess weight loss percent-
age, EWLkg 1/2 years excess weight loss in 1 and 2 years’ time in kilo-
grams, Prior CC prior cholecystectomy, Prior GB prior gastric banding,
Prior other operation included all surgical operations in the abdomen like
ventral hernia and fundoplication
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